BIDOSINE Trademark

Trademark Overview

On Thursday, August 16, 2007, a trademark application was filed for BIDOSINE with the United States Patent and Trademark Office. The USPTO has given the BIDOSINE trademark a serial number of 77257135. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, August 11, 2017. This trademark is owned by ADENOBIO N.V.. The BIDOSINE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for treating cardiovascular diseases, namely, ischemic heart diseases, cardiac insufficiency, hypertension, arrhythmias, thrombosis, atherosclerosis, peripheral arterial disease, restenosis, and shock resuscitation; pharmaceutical preparations for treating cerebral diseases, namely, stroke, brain ischemia and spinal cord ischemia; pharmaceutical preparations for treating inflammatory diseases associated to organ ischemia pathologies; pharmaceutical preparations for treating angiogenesis; pharmaceutical preparations for treating pulmonary diseases, namely, pulmonary hypertension; pharmaceutical preparations for the diagnosis of ischemia, namely, myocardial ischemia
bidosine

General Information

Serial Number77257135
Word MarkBIDOSINE
Filing DateThursday, August 16, 2007
Status710 - CANCELLED - SECTION 8
Status DateFriday, August 11, 2017
Registration Number3898369
Registration DateTuesday, January 4, 2011
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 19, 2010

Trademark Statements

Goods and ServicesPharmaceutical preparations for treating cardiovascular diseases, namely, ischemic heart diseases, cardiac insufficiency, hypertension, arrhythmias, thrombosis, atherosclerosis, peripheral arterial disease, restenosis, and shock resuscitation; pharmaceutical preparations for treating cerebral diseases, namely, stroke, brain ischemia and spinal cord ischemia; pharmaceutical preparations for treating inflammatory diseases associated to organ ischemia pathologies; pharmaceutical preparations for treating angiogenesis; pharmaceutical preparations for treating pulmonary diseases, namely, pulmonary hypertension; pharmaceutical preparations for the diagnosis of ischemia, namely, myocardial ischemia

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, August 11, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameADENOBIO N.V.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressLuchthaven Schipol 1118BH
NL
Party NameADENOBIO N.V.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressLuchthaven Schipol 1118BH
NL
Party NameADENOBIO N.V.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressLuchthaven Schipol 1118BH
NL

Trademark Events

Event DateEvent Description
Friday, August 11, 2017CANCELLED SEC. 8 (6-YR)
Tuesday, January 4, 2011REGISTERED-PRINCIPAL REGISTER
Tuesday, October 19, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 19, 2010PUBLISHED FOR OPPOSITION
Monday, September 13, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, September 7, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 2, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 2, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 30, 2010TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Sunday, May 9, 2010NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sunday, May 9, 2010LETTER OF SUSPENSION E-MAILED
Sunday, May 9, 2010SUSPENSION LETTER WRITTEN
Friday, May 7, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 7, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, May 3, 2010TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, November 5, 2009NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Thursday, November 5, 2009INQUIRY TO SUSPENSION E-MAILED
Thursday, November 5, 2009SUSPENSION INQUIRY WRITTEN
Wednesday, November 4, 2009LIE CHECKED SUSP - TO ATTY FOR ACTION
Wednesday, November 4, 2009ASSIGNED TO LIE
Thursday, April 30, 2009NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, April 30, 2009LETTER OF SUSPENSION E-MAILED
Thursday, April 30, 2009SUSPENSION LETTER WRITTEN
Thursday, April 30, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 30, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 28, 2009TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, October 28, 2008NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Tuesday, October 28, 2008INQUIRY TO SUSPENSION E-MAILED
Tuesday, October 28, 2008SUSPENSION INQUIRY WRITTEN
Thursday, October 23, 2008LIE CHECKED SUSP - TO ATTY FOR ACTION
Thursday, October 23, 2008ASSIGNED TO LIE
Wednesday, April 23, 2008NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, April 23, 2008LETTER OF SUSPENSION E-MAILED
Wednesday, April 23, 2008SUSPENSION LETTER WRITTEN
Tuesday, April 22, 2008TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 22, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 22, 2008TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, November 28, 2007NOTIFICATION OF PRIORITY ACTION E-MAILED
Wednesday, November 28, 2007PRIORITY ACTION E-MAILED
Wednesday, November 28, 2007PRIORITY ACTION WRITTEN
Monday, November 26, 2007ASSIGNED TO EXAMINER
Tuesday, August 21, 2007NEW APPLICATION ENTERED IN TRAM

Related Keywords

bidosine pharmaceutical preparations ischemia diseases treating namely pulmonary hypertension spinal cord